News Category
The latest DH Unplugged episode highlights Michael Burry's bearish bets against Nvidia and Tesla, Nvidia's unprecedented $500 billion AI financing usi...
Regentis Biomaterials' new patent for its solvent-free manufacturing process strengthens its IP portfolio and supports scaling up production of its of...
VERAXA Biotech's collaboration with Ardigen aims to use AI to identify optimal dual-target combinations for cancer therapies, potentially reviving aba...
VERAXA Biotech's collaboration with Ardigen aims to use AI to optimize its BiTAC platform, potentially improving target validation and reducing develo...
Monica Brant, a legendary fitness figure, has become a brand ambassador for N1o1, endorsing Dr. Nathan Bryan's science-based nitric oxide products, un...
Researchers have identified a protein on glioblastoma cells that, when targeted, could make the cancer more vulnerable to existing treatments, potenti...
Nanox Imaging's subsidiary signs an exclusive UK reseller agreement with Vertec Scientific for its AI bone solution HealthOST, following NICE's recomm...
NanoViricides expects to begin a Phase II clinical trial of its oral antiviral NV-387 for Ebola in the Democratic Republic of Congo, highlighting a po...
Helus Pharma's appointments of Regina Donohue as Chief People Officer and Suresh Durgam to its Scientific Advisory Board signal strategic preparation ...
SS Innovations International's record Q2 revenue and expanding installed base for its SSi Mantra robotic surgery system highlight the company's growth...
Wolfson Group emphasizes the mainstream shift in consumer interest toward the gut microbiome, influencing product development and communication strate...
Freyja Healthcare’s VereSee™ Mini Laparoscope with VisualEntry™ System has received FDA 510(k) clearance, enabling visualization during laparoscopic e...
Discover Healing will host a free live webinar on August 27 to demonstrate how to release trapped emotions using The Emotion Code, offering real-time ...
REPLOID Group AG plans a 1:15 stock split to lower its share price and enhance tradability, aiming to attract more retail investors.
Helix BioPharma strengthens its leadership with the appointment of Dr. Markus Loeffler as CMO to guide its oncology pipeline through upcoming clinical...
SCHOTT Pharma's updated climate targets, validated by the Science Based Targets initiative, introduce a new absolute Scope 3 emissions reduction goal,...
Quantum BioPharma reported reduced Q2 expenses and FDA clearance to start Phase 2 trials for its multiple sclerosis drug, positioning the company for ...
Regentis Biomaterials is simultaneously progressing its GelrinC cartilage repair implant through a pivotal US Phase III trial and European commercial ...
Dyadic International's $2.9 million capital raise underscores investor confidence in its proprietary protein production platforms, positioning the com...
Alpha Cognition's Q2 2026 earnings show ZUNVEYL demand accelerating, with net product revenue up 71% quarter-over-quarter, despite payer access still ...
Streamex Corp. announced its second-quarter 2026 financial results and scheduled a business update call to discuss its progress in commodity tokenizat...
Two young scientists receive $200,000 each to pursue innovative research on lung cancer early detection and drug resistance, highlighting the critical...
PX1 Research's new seven-stage testing protocol for domestically manufactured research peptides ensures 99%+ purity with full documentation, addressin...
Velaris Med Spa now offers provider-led Morpheus8 treatments in Burley, Idaho, bringing advanced skin tightening technology to the Magic Valley region...
Knecht Orthodontics, led by Dr. Kristen Knecht, now offers braces and Invisalign to Anahuac families at its Mont Belvieu office, reducing travel and p...
A comprehensive review in World Journal of Pediatric Surgery synthesizes evidence on surgical management of NEC, emphasizing bowel preservation and in...
Helix BioPharma reshapes its board to align with strategic goals, appointing CEO Thomas Mehrling as director following Janusz Grabski's resignation.
Vycor Medical announced its Q2 2026 financial results, showing a 17% revenue decline in its medical division but highlighting three new peer-reviewed ...
Onco-Innovations is building the manufacturing and scientific foundation for its nanoparticle-encapsulated PNKP inhibitor ONC010, aiming to advance bi...
SS Innovations International's record Q2 revenue and growing adoption of its SSi Mantra robotic system signal significant progress in global surgical ...
Regentis Biomaterials' new Japanese patent for its organic solvent-free manufacturing process and ready-to-use liquid formulation of GelrinC strengthe...
Regentis Biomaterials' GelrinC hydrogel implant gains European approval for scalable manufacturing, positioning it to disrupt the multi-billion knee c...
Gaxos.ai's warrant exercise agreement will inject $3.6 million into the company, supporting its mission to develop AI solutions across defense, health...
Researchers at the University of Manchester found that a small group of immune cells, previously understudied, plays a crucial role in mobilizing the ...
Quantum BioPharma reported reduced Q2 expenses and received FDA approval for its Phase 2 trial of Lucid-MS, a potential treatment for progressive mult...
Regentis Biomaterials is strategically advancing its cartilage repair product GelrinC through parallel U.S. clinical trials and European commercializa...
HeartBeam's recent progress in clinical trials, product development, and initial commercialization positions it to potentially transform heart attack ...
Lantern Pharma reported Q2 2026 results highlighting pipeline progress and the establishment of Open Medicine AI as a separate company, marking a stra...
Redwood AI's acquisition of Quantum.IQ Technologies marks a strategic expansion into quantum cybersecurity, addressing the emerging threat of quantum-...
Helus Pharma's completion of enrollment in its pivotal Phase 3 APPROACH trial for HLP003 in major depressive disorder brings the company closer to a p...
DM Clinical Research celebrates its 20th anniversary, highlighting its growth into a leading clinical research network with over 35 sites and 35,000 p...
Burcon's fiscal Q1 2027 results show significant revenue growth and customer expansion, but the company faces a substantial second-half ramp to meet i...
NeOnc Technologies' NEO100 meets primary endpoint in Phase 2a for recurrent brain cancer, with survival signals and FDA alignment advancing both NEO10...
PX1 Research's new batches of Retatrutide and Tirzepatide peptides, manufactured in USA cGMP facilities with HPLC batch verification, ensure high puri...
Quantum BioPharma's Lucid-MS focuses on inhibiting myelin degradation to address progression independent of relapse activity, a key driver of long-ter...
Carolina Age Management Institute has rebranded as Cami Aesthetics, signaling a strategic evolution to unify its two North Carolina locations under a ...
GeoVax emphasizes the potential of its MVA-based vaccine candidates and expertise to contribute to the global response against the escalating Bundibug...
SS Innovations International announced record second-quarter revenue and a significant increase in SSi Mantra installations, underscoring its growth t...
